Shilpa Medicare Ltd
BSE : 530549
NSE : SHILPAMED
Sector :Health care
ISIN Code : INE790G01031
NSE
765.35
-1.30 (-0.17%)
Open
767.00
High
778.00
Low
760.00
BSE
766.50
0.55 (0.07%)
Open
801.15
High
801.15
Low
760.00
Indian Regulatory Authority - SEC Approval For Conducting Phase III Clinical Trials For Recombinant Human Albumin (Rha) 20%
04:01 PM,26th Dec 2024
Indian Regulatory Authority - SEC approval for conducting Phase III clinical trials for Recombinant Human Albumin (eHA) 20%
